Discover how advanced PK/PD and in vivo efficacy models drive drug development from discovery to preclinical milestones.
This session highlights case studies in oncology, immunology, and fibrosis, showcasing how validated and custom platforms provide predictive insights, confirm mechanisms of action, and support faster, smarter decision-making.
Watch now to see how integrated in vivo strategies — from biomarker analysis to digital histopathology — can accelerate your path toward IND-enabling success.
Malavika Ghosh, PhD
Senior VP and Head, Global Preclinical Research Services, Aragen Bioscience
Linh Nguyen, PhD
Director, Oncology & Immunology, Global Preclinical Research Services, Aragen Bioscience
